Insiders Buying Zumiez And 3 Other Stocks
Insiders Buying Zumiez And 3 Other Stocks
Although U.S. stocks closed little changed on Monday, there were a few notable insider trades.
儘管週一美國股市收盤變化不大，但仍有一些值得注意的內幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
當內部人士購買股票時，這表明他們對公司前景充滿信心，或者他們認爲股票很划算。無論哪種方式，這都預示着做多該股的機會。不應將內幕購買視爲做出投資或交易決策的唯一指標。充其量，它可以爲購買決定提供信心。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近一些值得注意的內幕收購。欲了解更多，請查看 本辛加的內幕交易 平台。
Semtech
Semtech
- The Trade: Semtech Corporation (NASDAQ:SMTC) EVP and CFO Mark Lin acquired a total of 1,000 shares an average price of $33.23. To acquire these shares, it cost around $33,232.
- What's Happening: On March 28, Semtech posted a loss for the fourth quarter.
- What Semtech Does: Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT.
- 貿易：Semtech Corporation（納斯達克股票代碼：SMTC）執行副總裁兼首席財務官馬克·林 共收購了 1,000 股股份 平均價格爲33.23美元。收購這些股票的成本約爲33,232美元。
- 發生了什麼：3月28日，Semtech公佈了第四季度的虧損。
- Semtech做什麼：Semtech Corp從事設計、開發、製造和銷售模擬和混合信號半導體、算法和無線半導體、連接模塊、網關、路由器和物聯網的互聯服務。
Greif
格雷夫
- The Trade: Greif, Inc. (NYSE:GEF) Executive VP & General Counsel Gary R Martz acquired a total of 10,082 shares at an average price of $68.23. To acquire these shares, it cost around $687,932.
- What's Happening: On Feb. 28, Greif posted upbeat quarterly earnings.
- What Greif Does: Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries.
- 交易：格雷夫公司（紐約證券交易所代碼：GEF）執行副總裁兼總法律顧問加里·馬茨共收購了10,082股股票，平均價格爲68.23美元。收購這些股票的成本約爲687,932美元。
- 發生了什麼：2月28日，格雷夫公佈了樂觀的季度收益。
- 格瑞夫做什麼：Greif Inc是一家工業包裝產品和服務生產商，其製造工廠遍佈多個國家。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
Zumiez
Zumiez
- The Trade: Zumiez Inc. (NASDAQ:ZUMZ) President International Adam Christopher Ellis bought a total of 10,000 shares at an average price of $14.31. To acquire these shares, it cost around $143,100.
- What's Happening: On March 20, B. Riley Securities analyst Jeff Van Sinderen maintained Zumiez with a Neutral and lowered the price target from $19 to $16.
- What Zumiez Does: Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods.
- 貿易：Zumiez Inc.（納斯達克股票代碼：ZUMZ）國際總裁亞當·克里斯托弗·埃利斯 總共買入了1萬股 平均價格爲14.31美元。收購這些股票的成本約爲143,100美元。
- 發生了什麼：3月20日，B. Riley Securities分析師傑夫·範·辛德倫維持Zumiez的中性立場，並將目標股價從19美元下調至16美元。
- Zumiez 做什麼：Zumiez Inc是一家總部位於美國的專業零售商，從事服裝、鞋類、配飾和耐用品的銷售。
AngioDynamics
血管動力學
- The Trade: AngioDynamics, Inc. (NASDAQ:ANGO) President and CEO James C Clemmer bought a total of 10,000 shares at an average price of $6.70. The insider spent around $67,000 to buy those shares.
- What's Happening: On April 4, AngioDynamics received FDA 510(k) clearance For AlphaVac F1885 System For Pulmonary Embolism.
- What AngioDynamics Does: AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
- 貿易：AngioDynamics, Inc.（納斯達克股票代碼：ANGO）總裁兼首席執行官詹姆斯·克萊默 總共買入了1萬股 平均價格爲6.70美元。知情人士花費了約67,000美元購買了這些股票。
- 發生了什麼：4月4日，AngioDynamics獲得了美國食品藥品管理局針對肺栓塞的AlphaVac F1885 系統的510（k）許可。
- AngioDynamics的作用：AngiOdynamics Inc設計、製造和銷售醫療、外科和診斷設備，供專業醫療保健提供商用於治療外周血管疾病以及用於腫瘤和外科手術環境。
譯文內容由第三人軟體翻譯。